Emad Estemalik MD, MBA is the Chair for International Business Development at Cleveland Clinic’s International Operations, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute and Assistant Professor of Neurology at the Lerner School of Medicine of Case Western Reserve University.

He joined the Cleveland Clinic as Staff in 2013. He is board certified by the American Board of Psychiatry and Neurology and Headache Medicine by the United Council for Neurological Subspecialties. . He is a member of the American headache society.

Dr. Estemalik completed his residency at the Cleveland Clinic in 2012. He also completed a one year fellowship in Headache Medicine following his residency. He received his MD from the Ain – Shams medical school in Cairo, Egypt in 2005. He is also a graduate of the Weatherhead School of Management at Case Western Reserve University from which he holds an MBA degree.

Dr. Estemalik leads the efforts of expanding the Cleveland Clinic’s global outreach to enhance the Clinic’s international presence, direct its international resources towards building quality relationships with global healthcare institutions and identifying strategic market opportunities to direct investment strategies.

Dr. Estemalik also serves on the leadership committee of the Cleveland Clinic’s Neurological Institute. His role includes executing the Cleveland Clinic’s vision and help achieve a high – performing institute while integrating education, research and medical innovation. His focus is to enhance the capabilities of medical informatics while directing the institute’s programmatic domestic and international growth and further enhance the development of service lines that better serve patients. He also sits on the Neurological Institute’s marketing and philanthropy committee.

Dr. Estemalik speaks Arabic, German, French and Spanish. Born in Cairo, Egypt, he lived in various countries of the Middle East in addition to several years in Hamburg, Germany.

Dr. Estemalik’s areas of interests are migraine headaches, trigeminal autonomic cephalgias and facial neuralgias. He is a national and international speaker on various topics of headache disorders and its comorbidities. He is an active participant in various headache clinic trials at the Cleveland Clinic. He is an active reviewer for Cleveland Clinic’s journal of medicine, Pain Practice Journal and the Egyptian Journal of Neurology and Neurosurgery. He consults and serves on faculty advisory boards of Lundbeck, Lilly, AbbVie and Teva pharmaceuticals.